---
title: "This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294709682.md"
description: "Wall Street analysts initiated coverage on several stocks with bullish outlooks. Compass Point's Ed Engel started coverage on Charles Schwab (SCHW) with a Buy rating and $135 price target, noting its Friday close at $105.24. BTIG's Julian Harrison initiated Yarrow Bioscience (YARW) with a Buy rating and $58 target, while Wells Fargo's Derek Archila covered Pyxis Oncology (PYXS) with an Overweight rating and $12 target."
datetime: "2026-08-03T14:24:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294709682.md)
  - [en](https://longbridge.com/en/news/294709682.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294709682.md)
generator: "portal-rs"
---

# This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Compass Point analyst Ed Engel initiated coverage on **Charles Schwab Corporation** (NYSE:SCHW) with a Buy rating and announced a price target of $135. Charles Schwab closed at $105.24 on Friday. See how other analysts view this stock.
-   BTIG analyst Julian Harrison initiated coverage on **Yarrow Bioscience Inc** (NASDAQ:YARW) with a Buy rating and announced a price target of $58. Yarrow Bioscience shares closed at $35.02 on Friday. See how other analysts view this stock.
-   Wells Fargo analyst Derek Archila initiated coverage on **Pyxis Oncology Inc** (NASDAQ:PYXS) with an Overweight rating and announced a price target of $12. Pyxis Oncology closed at $2.65 on Friday. See how other analysts view this stock.

Considering buying SCHW stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [YARW.US](https://longbridge.com/en/quote/YARW.US.md)
- [SCHW.US](https://longbridge.com/en/quote/SCHW.US.md)
- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)
- [SCHW-D.US](https://longbridge.com/en/quote/SCHW-D.US.md)
- [SCHW-J.US](https://longbridge.com/en/quote/SCHW-J.US.md)

## Related News & Research

- [Here’s How Much You Would Have Made Owning Charles Schwab Stock In The Last 15 Years](https://longbridge.com/en/news/298947098.md)
- [Analyst Maintains Buy Rating on PYXS and Reiterates $6 Price Target on Promising MICVO Data](https://longbridge.com/en/news/298490068.md)
- [Charles Schwab (SCHW) Brings AI Tools To 16,000 Advisors](https://longbridge.com/en/news/299019891.md)
- [Pyxis Oncology Analyst Flags Key Safety Liabilities from Cancer Drug](https://longbridge.com/en/news/298491342.md)
- [Yarrow Bioscience Announces Underwritten Equity Offering Agreement](https://longbridge.com/en/news/298965126.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**